Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Middle-aged and elderly men with BPH had higher hospitalization rates for COVID-19.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

Some recovered COVID-19 patients experience skin, hair, and nail issues, suggesting they need follow-up care.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

Natural compounds, especially Withaferin-A, may help treat post-COVID-19 complications, but some may have side effects.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

Blood type affects COVID-19 infection rates differently in Europe and Africa.

Long-term effects of COVID-19 can vary over time and are more likely in certain age and gender groups, while race, income, and education levels have little to no impact. Ongoing medical care is needed due to potential complications.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Some people still have COVID-19 symptoms after 90 days, especially older patients and those with severe initial symptoms, but most return to normal.

The article suggests using safety measures and telemedicine for aesthetic dermatology during COVID-19, while some procedures can still be done safely.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

Public interest in skin issues changed during COVID-19, with more focus on dry skin, hair problems, and hand eczema.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.